Pioglitazone
Product Images NDC 71335-1137

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 71335-1137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 1)

Chemical structure of pioglitazone hydrochloride, showing its aromatic rings, thiazolidinedione moiety, and hydrochloride salt component as depicted in the molecular diagram.*

FDA Label Image

Figure 1 (Image 2)

A line graph showing mean values over 26 weeks for Pioglitazone doses (15 mg, 30 mg, 45 mg) compared to placebo. The x-axis represents weeks, and the y-axis represents the mean measurement. Different symbols and colors distinguish placebo and each dose group.*

FDA Label Image

Label Image (Lbl713351137)

Pioglitazone HCl 15mg tablet label from Bryant Ranch Prepack, packaged in Burbank, CA. The label indicates a comparison to Actos 15mg tablet by Teva Pharmaceuticals. It includes storage instructions at room temperature (20°-25°C), a drug safety warning to keep out of reach of children, and displays the NDC 71335-1137 in barcode and numeric format. Quantity indicated as 30 tablets with expiration date placeholder.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.